发布: 2016年01月20日第6卷第2期 DOI: 10.21769/BioProtoc.1718 浏览次数: 7400
评审: Jia LiRamalingam BethunaickanAnonymous reviewer(s)
Abstract
Hepatitis B virus (HBV) can cause both acute and chronic disease in human liver with potentially high risk of cirrhosis and liver cancer. The host range of non-human primates susceptible to this virus is limited. Therefore, experimental studies with human hepatocyte-chimeric mice provide an invaluable source of information regarding the biology and pathogenesis of HBV. This section describes the protocol for infection of the human hepatocyte-chimeric mice with HBV. In addition, it has recently been shown that HBV replication can be suppressed by exogenous expression of viral epsilon RNA (εRNA; Sato et al., 2015), which serves as an encapsidation signal (Bartenschlager et al., 1992). Based upon this finding, we also describe the protocol for the liposome-mediated delivery of a plasmid encoding εRNA to liver in these chimeric mice.
Keywords: Hepatitis B virus (乙型肝炎病毒)Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2016 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Sato, S., Li, K. and Takaoka, A. (2016). Infection of Human Hepatocyte-chimeric Mice with HBV and in vivo Treatment with εRNA. Bio-protocol 6(2): e1718. DOI: 10.21769/BioProtoc.1718.
分类
微生物学 > 微生物-宿主相互作用 > 体内实验模型
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link